FR2715304B1 - Vaccin anti-allergique. - Google Patents

Vaccin anti-allergique.

Info

Publication number
FR2715304B1
FR2715304B1 FR9400846A FR9400846A FR2715304B1 FR 2715304 B1 FR2715304 B1 FR 2715304B1 FR 9400846 A FR9400846 A FR 9400846A FR 9400846 A FR9400846 A FR 9400846A FR 2715304 B1 FR2715304 B1 FR 2715304B1
Authority
FR
France
Prior art keywords
allergic vaccine
vaccine
allergic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR9400846A
Other languages
English (en)
Other versions
FR2715304A1 (fr
Inventor
Christian Marcel Hurpin
Mireille Jeanne Marguer Panero
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Pasteur SA
Original Assignee
Pasteur Merieux Serum et Vaccines SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pasteur Merieux Serum et Vaccines SA filed Critical Pasteur Merieux Serum et Vaccines SA
Priority to FR9400846A priority Critical patent/FR2715304B1/fr
Priority to AU15388/95A priority patent/AU1538895A/en
Priority to PCT/FR1995/000034 priority patent/WO1995020606A1/fr
Publication of FR2715304A1 publication Critical patent/FR2715304A1/fr
Application granted granted Critical
Publication of FR2715304B1 publication Critical patent/FR2715304B1/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/42—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins
    • C07K16/4283—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an allotypic or isotypic determinant on Ig
    • C07K16/4291—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an allotypic or isotypic determinant on Ig against IgE

Landscapes

  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
FR9400846A 1994-01-26 1994-01-26 Vaccin anti-allergique. Expired - Fee Related FR2715304B1 (fr)

Priority Applications (3)

Application Number Priority Date Filing Date Title
FR9400846A FR2715304B1 (fr) 1994-01-26 1994-01-26 Vaccin anti-allergique.
AU15388/95A AU1538895A (en) 1994-01-26 1995-01-11 Anti-allergic vaccine
PCT/FR1995/000034 WO1995020606A1 (fr) 1994-01-26 1995-01-11 Vaccin anti-allergique

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9400846A FR2715304B1 (fr) 1994-01-26 1994-01-26 Vaccin anti-allergique.

Publications (2)

Publication Number Publication Date
FR2715304A1 FR2715304A1 (fr) 1995-07-28
FR2715304B1 true FR2715304B1 (fr) 1996-04-26

Family

ID=9459430

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9400846A Expired - Fee Related FR2715304B1 (fr) 1994-01-26 1994-01-26 Vaccin anti-allergique.

Country Status (3)

Country Link
AU (1) AU1538895A (fr)
FR (1) FR2715304B1 (fr)
WO (1) WO1995020606A1 (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100498198B1 (ko) * 1996-03-01 2005-09-09 노파르티스 아게 알레르기에 대한 백신접종 및 치료를 위한 펩티드 임뮤노겐
TW480282B (en) * 1996-04-24 2002-03-21 Ren Wen Corp Recombinant eucaryotic vector containing allergen gene and use of preventing and treating allergic disease thereof
WO1998024808A2 (fr) * 1996-12-06 1998-06-11 THE UNITED STATES OF AMERICA represented by THE SECRETARY DEPARTMENT OF HEALTH & HUMAN SERVICES, THE NATIONAL INSTITUTES OF HEALTH Inhibition d'allergies provoquees par l'immunoglobuline e grace a un oligopeptide derive de l'immunoglobuline e humaine
US6913749B2 (en) 1998-11-02 2005-07-05 Resistentia Pharmaceuticals Ab Immunogenic polypeptides for inducing anti-self IgE responses
EP1621209A3 (fr) * 1998-11-02 2006-04-19 Resistentia Pharmaceuticals AB Vaccins qui se basent sur des domaines de peptides originaires d'immunoglobuline E
EP2361635A3 (fr) * 2000-08-30 2011-09-14 Pfizer Products Inc. Anti-IgE vaccins
IL154219A0 (en) * 2000-09-06 2003-07-31 Pharmexa As Method for down-regulating ige
EP2687593A1 (fr) * 2001-05-15 2014-01-22 Ortho-McNeil Pharmaceutical, Inc. Amorçage ex-vivo de génération de lymphocytes T cytotoxiques spécifiques pour des antigènes sans tumeur dans le traitement de maladies auto-immunes et allergiques

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8616166D0 (en) * 1986-07-02 1986-08-06 Research Corp Ltd Polypeptide competitor
GB8727045D0 (en) * 1987-11-19 1987-12-23 Research Corp Ltd Immunoglobulin e competitor
SE9102808L (sv) * 1991-09-26 1993-03-27 Lars T Hellman Inst F Immunolo Vaccin, foer humant bruk, vars avsedda effekt aer att lindra symptomen eller foerhindra uppkomsten av ige-medierade allergiska reaktioner

Also Published As

Publication number Publication date
FR2715304A1 (fr) 1995-07-28
AU1538895A (en) 1995-08-15
WO1995020606A1 (fr) 1995-08-03

Similar Documents

Publication Publication Date Title
BR9711853A (pt) Vacinas
NO20003303D0 (no) Vaksine
DZ2462A1 (fr) Vaccin antigrippal.
NO996133D0 (no) Olje-i-vann-vaksinesammensetninger
DK0810877T3 (da) Hepatitis B-vaccine
FI971279A (fi) Lääkkeitä
NO20006191D0 (no) Vaksine
DZ2283A1 (fr) Composition de vaccin.
NL1006015A1 (nl) Toedieninrichting.
DE69629457D1 (de) Impfstoff in gelform
TR199501082A2 (tr) Farmasötik formülasyonlar.
FR2715304B1 (fr) Vaccin anti-allergique.
ATE253641T1 (de) Antigenische präparationen
NO20005599L (no) Vaksine
EE03356B1 (et) 14a, 17a-C2-sildunud 19-nor-progesteroonderivaadid
NL300165I2 (nl) Babesiavaccin.
NL1001230C1 (nl) Voetsteun.
FR2719994B1 (fr) Béquilles.
ES1029017Y (es) Almohada terapeutica.
IT1268116B1 (it) Sedia.
DE69326536D1 (de) Antitumor Impfstoff
KR970703417A (ko) 유두종 바이러스 백신(Papillomavirus vaccines)
ES1028135Y (es) Almohada supercervical.
IT232560Y1 (it) Dispositivo per magnetoterapia.
ES1029732Y (es) Almohada cervical.

Legal Events

Date Code Title Description
ST Notification of lapse